What does legacy reinsurance — fee revenue mean?

Includes income generated from services provided by the legacy reinsurance segment that are not directly related to underwriting premiums. This represents non-risk-based revenue streams that diversify the segment's earnings.

King Pharmaceuticals KG Legacy Reinsurance — Fee revenue

Similar metrics at other companies

RWTLegacy Investments — Fee income, net

-$133K+84.7%

EGLegacy — Underwriting Income (Loss)

-$22M-57.1%

LUMNLegacy — Revenue Not from Contract with Customer

$41M-2.4%

EGLegacy — Premiums earned

$399M-26.1%

EGLegacy — Commission and brokerage

$41M-6.8%

AXSReinsurance — Other insurance related income

$5.28M+54.3%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FeeIncome.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — fee revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — fee revenue?: King Pharmaceuticals (KG) reported legacy reinsurance — fee revenue of $0 in Q1 2026.
What does legacy reinsurance — fee revenue mean?: Includes income generated from services provided by the legacy reinsurance segment that are not directly related to underwriting premiums. This represents non-risk-based revenue streams that diversify the segment's earnings.